David Moreira

AI is a viable alternative to high throughput screening: a 318-target study

Izhar Wallach, Denzil Bernard, Kong T. Nguyen et al. · Scientific Reports · 2024 · 120 citations · Full text

Pharmacy, Bioinformatics, Medicinal Chemistry +16

Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors

Shubaash Anthiya, Süleyman Can Öztürk, Ece Tavukçuoğlu et al. · Journal of Controlled Release · 2023 · 91 citations · Full text

Pharmacy, Cancer Biology, Oncology +17

Evaluation of human umbilical vein endothelial cells growth onto heparin-modified electrospun vascular grafts

Pablo C. Caracciolo, Patricia Díaz‐Rodríguez, Inés Ardao et al. · International Journal of Biological Macromolecules · 2021 · 22 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +11

Nanoemulsions and nanocapsules as carriers for the development of intranasal mRNA vaccines

Mireya L. Borrajo, Gustavo Lou, Shubaash Anthiya et al. · Drug Delivery and Translational Research · 2024 · 18 citations · Full text

Pharmacy, Infectious Diseases, Pharmaceutics +17

The M2-type isoenzyme of pyruvate kinase phosphorylates prothymosin α in proliferating lymphocytes

Cristina Dı́az-Jullien, David Moreira, Concepción S. Sarandeses et al. · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 2010 · 11 citations

Life Sciences, Biochemistry, Cell Biology +8